Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the page; these are contextual and do not alter core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-31T17:14:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Utah to the Locations section and updated the revision to v3.3.3. Removed Utah Locations and several related topics, including HHS Vulnerability Disclosure, MedlinePlus Genetics, and Melanoma.
    Difference
    0.4%
    Check dated 2025-12-24T14:45:40.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-10T00:40:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a new site revision entry: Revision: v3.3.2. Removed the Melanoma topic and the related MedlinePlus Genetics topic, as well as the older Revision: v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-25T14:15:45.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Removal of the government funding/operating status banner from the bottom of the page. This change does not affect the study details, eligibility criteria, or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:28:17.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A MedlinePlus Genetics related topic for Melanoma has been added to the page. This is a minor informational enhancement that does not affect study details or user workflows.
    Difference
    0.9%
    Check dated 2025-10-27T21:06:10.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.